Suppr超能文献

进化重要性的残基和残基对差异地指导 D2 多巴胺受体的信号转导偏向。

Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors.

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030.

Graduate Program in Integrative Molecular and Biomedical Sciences, Baylor College of Medicine, Houston, Texas 77030.

出版信息

J Biol Chem. 2019 Dec 13;294(50):19279-19291. doi: 10.1074/jbc.RA119.008068. Epub 2019 Nov 1.

Abstract

The D2 dopamine receptor and the serotonin 5-hydroxytryptamine 2A receptor (5-HT2A) are closely-related G-protein-coupled receptors (GPCRs) from the class A bioamine subfamily. Despite structural similarity, they respond to distinct ligands through distinct downstream pathways, whose dysregulation is linked to depression, bipolar disorder, addiction, and psychosis. They are important drug targets, and it is important to understand how their bias toward G-protein β-arrestin signaling pathways is regulated. Previously, evolution-based computational approaches, difference Evolutionary Trace and Evolutionary Trace-Mutual information (ET-Mip), revealed residues and residue pairs that, when switched in the D2 receptor to the corresponding residues from 5-HT2A, altered ligand potency and G-protein activation efficiency. We have tested these residue swaps for their ability to trigger recruitment of β-arrestin2 in response to dopamine or serotonin. The results reveal that the selected residues modulate agonist potency, maximal efficacy, and constitutive activity of β-arrestin2 recruitment. Whereas dopamine potency for most variants was similar to that for WT and lower than for G-protein activation, potency in β-arrestin2 recruitment for N124H was more than 5-fold higher. T205M displayed high constitutive activity, enhanced dopamine potency, and enhanced efficacy in β-arrestin2 recruitment relative to WT, and L379F was virtually inactive. These striking differences from WT activity were largely reversed by a compensating mutation (T205M/L379F) at residues previously identified by ET-Mip as functionally coupled. The observation that the signs and relative magnitudes of the effects of mutations in several cases are at odds with their effects on G-protein activation suggests that they also modulate signaling bias.

摘要

D2 多巴胺受体和 5-羟色胺 5-羟色胺 2A 受体(5-HT2A)是密切相关的 G 蛋白偶联受体(GPCR),来自 A 类生物胺亚家族。尽管结构相似,但它们通过不同的下游途径对不同的配体作出反应,其失调与抑郁症、双相情感障碍、成瘾和精神病有关。它们是重要的药物靶点,了解它们对 G 蛋白 β-arrestin 信号通路的偏向性如何调节非常重要。以前,基于进化的计算方法,差异进化轨迹和进化轨迹-互信息(ET-Mip),揭示了残基和残基对,当它们在 D2 受体中被 5-HT2A 的相应残基取代时,改变了配体的效力和 G 蛋白的激活效率。我们已经测试了这些残基替换在多巴胺或血清素刺激下触发β-arrestin2 募集的能力。结果表明,选定的残基调节激动剂的效力、最大功效和β-arrestin2 募集的组成活性。虽然大多数变体的多巴胺效力与 WT 相似且低于 G 蛋白激活,但 N124H 的效力高于 5 倍以上。T205M 显示出高组成活性、增强的多巴胺效力和增强的β-arrestin2 募集功效,与 WT 相比,而 L379F 几乎没有活性。这些与 WT 活性的显著差异在很大程度上被 ET-Mip 先前鉴定为功能耦合的残基的补偿性突变(T205M/L379F)所逆转。观察到在几种情况下,突变的作用的符号和相对大小与它们对 G 蛋白激活的作用不一致,这表明它们也调节信号偏向性。

相似文献

1
Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors.
J Biol Chem. 2019 Dec 13;294(50):19279-19291. doi: 10.1074/jbc.RA119.008068. Epub 2019 Nov 1.
2
Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3539-44. doi: 10.1073/pnas.1516579113. Epub 2016 Mar 15.
3
Dopamine DL receptor density influences the recruitment of β-arrestin2 and G1 induced by antiparkinsonian drugs.
Neuropharmacology. 2022 Apr 1;207:108942. doi: 10.1016/j.neuropharm.2022.108942. Epub 2022 Jan 10.
4
Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant.
ACS Chem Neurosci. 2021 Jun 2;12(11):1873-1884. doi: 10.1021/acschemneuro.0c00712. Epub 2021 May 11.
5
On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
J Mol Biol. 2011 Mar 11;406(5):687-99. doi: 10.1016/j.jmb.2011.01.022. Epub 2011 Jan 20.
6
7
Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
Neuropharmacology. 2008 Jun;54(8):1215-22. doi: 10.1016/j.neuropharm.2008.03.015. Epub 2008 Apr 8.
9
Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.
J Biol Chem. 2014 Nov 28;289(48):33663-75. doi: 10.1074/jbc.M114.605378. Epub 2014 Oct 21.
10
The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
J Biol Chem. 2018 Apr 20;293(16):6161-6171. doi: 10.1074/jbc.RA117.001300. Epub 2018 Feb 27.

本文引用的文献

1
The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface.
J Biol Chem. 2019 Apr 5;294(14):5604-5615. doi: 10.1074/jbc.RA118.004682. Epub 2019 Jan 22.
2
Discovery of β-arrestin-biased β-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives.
Acta Pharmacol Sin. 2019 Aug;40(8):1095-1105. doi: 10.1038/s41401-018-0200-x. Epub 2019 Jan 14.
3
Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets.
J Med Chem. 2018 Aug 9;61(15):6830-6845. doi: 10.1021/acs.jmedchem.8b00718. Epub 2018 Jul 24.
4
First GPCR-directed antibody passes approval milestone.
Nat Rev Drug Discov. 2018 Jun 28;17(7):457-459. doi: 10.1038/nrd.2018.103.
5
High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening.
Chem Sci. 2018 Feb 20;9(12):3192-3199. doi: 10.1039/c7sc04698g. eCollection 2018 Mar 28.
6
Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine.
Eur Neuropsychopharmacol. 2018 May;28(5):610-619. doi: 10.1016/j.euroneuro.2018.03.004. Epub 2018 Mar 21.
7
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
Curr Neuropharmacol. 2018;16(6):786-848. doi: 10.2174/1570159X16666180308161642.
8
Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
Cell Tissue Res. 2018 Jul;373(1):111-135. doi: 10.1007/s00441-018-2813-2. Epub 2018 Mar 7.
9
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone.
Nature. 2018 Mar 8;555(7695):269-273. doi: 10.1038/nature25758. Epub 2018 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验